On June 23, 2026, Nike (NYSE: NKE) announced it is replacing CFO Matthew Friend with former Pfizer CFO David Denton (effective August 17), while simultaneously revealing that Q4 FY2026 results — due June 30 — will include an unplanned tariff-refund benefit not in prior guidance. Nike shares closed down 1.88% at $42.38, leaving the stock down ~33% year-to-date.
Two things landed in Nike's announcement that most readers treated as one story. They're not.
First, the CFO swap. David Denton — ex-Pfizer, ex-Lowe's, ex-CVS — is stepping in for Matthew Friend on August 17. Denton's package: $1.45 million base salary, a $11.5 million long-term incentive target, and a $7.25 million sign-on cash award to replace what he's forfeiting at Pfizer. Friend gets a $2 million transition payment on the way out. That severance cost hits the P&L as an operating expense — real cash, real quarter.
Second, the tariff refund. Nike's Q4 results will include a one-time gain from tariff refunds that wasn't in earlier guidance. Management was careful to say: strip this out, and underlying performance is 'generally in line' with prior guidance. Translation — the base business hasn't improved; a government cheque made the headline number look better.
This is the single most important P&L skill a CFO has: separating recurring from non-recurring. Analysts call it 'adjusted' earnings — stripping out one-time items (severance charges, tariff windfalls, asset sale gains) to see the true run-rate of the business. Nike's own guidance does this explicitly. When you build a full P&L, always footnote the one-offs. Investors who miss this distinction get fooled every earnings season. Don't be that investor.
📚 Learn the concept: Build a Full P&L
Source: https://www.businesswire.com/news/home/20260623328558/en/NIKE-Inc.-Announces-Planned-CFO-Transition
▶ Play the 90-second CFO game All daily posts